Vol. 87, Issue 4, 1287-1295, October 1999
INVITED REVIEW
Theoretical and experimental intravascular gas embolism
absorption dynamics
Annette B.
Branger1 and
David
M.
Eckmann2
1 Department of Biomedical
Engineering, Northwestern University, Evanston, Illinois 60208; and
2 Department of Anesthesia and The
Institute for Medicine and Engineering, University of Pennsylvania,
Philadelphia, Pennsylvania 19104
 |
ABSTRACT |
Multifocal cerebrovascular gas
embolism occurs frequently during cardiopulmonary bypass and is thought
to cause postoperative neurological dysfunction in large numbers of
patients. We developed a mathematical model to predict the
absorption time of intravascular gas embolism, accounting for the
bubble geometry observed in vivo. We modeled bubbles as cylinders with
hemispherical end caps and solved the resulting governing gas transport
equations numerically. We validated the model using data obtained from
video-microscopy measurements of bubbles in the intact cremaster
microcirculation of anesthetized male Wistar rats. The theoretical
model with the use of in vivo geometry closely predicted actual
absorption times for experimental intravascular gas embolisms and was
more accurate than a model based on spherical shape. We computed
absorption times for cerebrovascular gas embolism assuming a range of
bubble geometries, initial volumes, and parameters relevant to brain blood flow. Results of the simulations demonstrated absorption time
maxima and minima based on initial geometry, with several configurations taking as much as 50% longer to be absorbed than would
a comparable spherical bubble.
air embolism; diffusion; microcirculation; mathematical model
 |
INTRODUCTION |
OVER 800,000 cardiopulmonary bypass
(CPB) surgeries are performed annually in the United States, with
~6-8% of patients experiencing a serious neurological morbid
event, including stroke or death (9, 22). The percentage
of patients experiencing lesser post-CPB cognitive dysfunction, such as
memory loss and attention deficit, has been estimated to be as high as
70% (24). The direct cause of the neurological changes is not clearly
defined; however, multifocal cerebrovascular gas embolism is compatible
with this type of morbidity and has been frequently implicated (16,
20). The number of microemboli (gaseous and particulate) occurring in
the cerebral circulation during CPB surgery has been attributed to both
the equipment and the surgical maneuvers used during the procedure and
is extremely difficult to reduce with present methods (9). The health
care costs associated with intravascular gas embolism (IGE) (prolonged
hospitalization, increased mortality, and the need for intermediate or
long-term care facilities) are, therefore, considerable (22).
Developing preventive measures or new treatment methods against the
injury suffered as a result of IGE would be extremely beneficial in
improving the safety and reducing the cost of patient care.
To develop new methods of prevention or treatment strategies, it is
necessary to understand the underlying mechanics behind IGE-induced
injury. One explanation for the decrease in neurological function after
multiple IGEs is that bubbles lodge in the cerebral blood vessels,
blocking blood flow and causing local transient ischemia (16,
18). Other studies suggest that the neurological injury is primarily
due to secondary thromboinflammatory responses activated by air-damaged
endothelium or interactions between blood constituents, such as
proteins and platelets, at the gas-liquid interface (15, 23). The
volume of the embolism decreases as the gas becomes absorbed into the
tissue, until the bubble either is completely dissolved or is displaced
to a new location downstream. The rate of bubble absorption is,
therefore, an important factor in the duration of ischemia and
reestablishment of blood flow in the region. Longer bubble absorption
times may exacerbate the provocation of thromboinflammatory and
endothelial responses.
We have developed a theoretical model specifically to predict the
absorption time of in vivo intravascular bubbles. Our model is based on
observations of in vivo IGE geometry. We conducted preliminary
experiments injecting small volumes of air into the intact rat
cremaster circulation. We observed that intravascular bubbles are not
spherical when they lodge and occlude blood flow. Rather, the bubbles
form elongated "sausagelike" shapes, completely filling the
vessel diameter. Similar observations have been reported by other
investigators as well (12, 18). One earlier model developed by Hlastala
and Van Liew (17) predicts the physiological absorption time of
spherical bubbles in tissue. Although that model has been applied to
gas bubbles in the circulation, it was created to describe the behavior
of extravascular spherical bubbles generated during decompression
sickness (11, 17).
Our theoretical model presented was validated by using data from animal
experiments conducted with the intact rat cremaster microcirculation.
After verification, this model was used to predict the residence time
of gas emboli of various volumes and initial geometries.
 |
MATERIALS AND METHODS |
Theoretical model.
To derive the governing transport equations for our theoretical model
and to solve for the total absorption time of an IGE, we made several
initial simplifying assumptions. We assumed rapid equilibrium of the
metabolic gases O2 and
CO2 and water vapor between the
bubble and the tissue, leaving N2
as the principal inert gas for diffusion. This assumption was made on
the basis that these metabolic gases constitute a small fraction of the air embolism volume and have a much higher tissue and blood
permeability than does the inert gas. The simultaneous exchange of
multiple gases in the theoretical model of a spherical bubble has
previously been addressed by Burkard and Van Liew (5). The initial
rapid efflux of N2 into the
tissue, at the instant of bubble entrapment, was neglected. In
addition, capillary perfusion was assumed to carry away the inert gas
in the tissue, preventing buildup and causing a decrease in partial
pressure of N2 away from the
bubble interface.
The initial configuration of the air embolism is modeled as a cylinder
with hemispherical end caps, based on in vivo observations from
preliminary experiments (Fig. 1,
A and
B). In vivo experiments also
demonstrated that, once the bubble became lodged in the smaller arterioles of the microcirculation, the diameter of the vessels remained essentially constant over the time course of gas absorption. Vasoconstriction occurred immediately on arrival of the bubble in the
vessel and persisted for the duration of the embolism resorption. After
the initial instant of entrapment, vasoconstriction had no additional
effect on lodged bubble geometry. The mathematical equations presented
below incorporate these additional in vivo findings by dictating that,
as the gas diffuses out of the IGE, the cylindrical portion of the
bubble decreases in length, while the radius of the end caps remains
fixed (Fig. 1C). The cylindrical portion eventually disappears, the remaining end caps fuse to form a
sphere, and the bubble shrinks as such (Fig.
1D).

View larger version (39K):
[in this window]
[in a new window]
|
Fig. 1.
In vivo and model intravascular gas bubble geometries.
A: microscopic view of air bubble
entrapped in rat cremaster arteriole. Bubble dimensions are length at
time 0 (l0) = 368 µm
and radius at time 0 (R0) = 33 µm.
B: model air embolism geometry at time
t = 0. C: model bubble shape for 0 < t < T1, where
T1 is time taken
for collapse of cylindrical portion, after partial gas absorption.
D: model air embolism configuration at
t = T1.
|
|
At the time of initial bubble entrapment, the bubble dimension in the
radial direction is bounded by the vessel wall, whereas the bubble
remains free to lengthen, creating an elongated cylinder with
hemispherical end caps. The difference between the pressure inside and
outside the bubble is balanced by the product of the surface tension
and the curvature at the gas-liquid interface. This pressure difference
(
P) is defined by Laplace's Law as
P = 2
/R, where
R is the bubble radius and
is the
value for surface tension. Because vessel radius showed little or no
change during absorption, interfacial shape of the end caps is assumed
to remain fixed during collapse of the cylindrical section, and the
internal pressure within the bubble also remains constant. Any increase in internal pressure would merely cause the bubble to elongate further.
A constant internal pressure creates a uniform driving force for gas
diffusion out of the bubble. It is not until the bubble is spherical
that the internal pressure changes. As gas diffuses out from the
sphere, the bubble radius decreases, causing an increase in bubble
internal pressure, an increased driving force for gas diffusion, and,
eventually, rapid bubble collapse.
Mathematically, this sequence can be represented in the following
manner. At the initial time point when the bubble lodges, t = 0, the length of the cylindrical
section of the bubble,
l(t), is l(0) = l0 (Fig.
1B). At
t = T1, the
cylindrical portion of the bubble has completely disappeared, i.e.,
l(T1) = 0, and the bubble becomes a sphere. During the time period 0
t
T1, the radius of
the hemispherical caps,
R(t),
remains fixed at
R(t) = R0. For
t > T1,
R(t)
decreases until time T, when the
bubble has completely collapsed,
R(T) = 0.
The absorption process can, therefore, be described for two discrete
increments in time: a cylindrical phase (0
t
T1) and a
spherical phase
(T1
t
T). Each portion is solved
independently. The cylindrical model was solved by using Fick's Law
|
(1)
|
in
which
Vb N2(t)
is the volume of the inert gas at standard conditions,
Pb N2[R(t)]
is the pressure inside the bubble,
PB is the barometric pressure,
and V(t) is the total volume of gas
in the bubble at ambient pressure. Following earlier models (17), we
equated the gas flux at the bubble interface at standard pressure to
the change in total bubble volume at ambient pressure, denoted in
Eq. 1. The diffusivity of
N2 in tissue is represented by
D, C is the concentration of the inert
gas in the tissue, and A is the
surface area of the bubble. Substituting in the appropriate A for our geometry and with the
expression
C =
ti
P, in
which the product of the solubility and the pressure of the inert gas in the tissue,
ti and P,
respectively, replacing the concentration, we get
|
(2)
|
The
volume of the bubble is given by
V(t) = 4
R30/3 +
R20l(t).
Because only the length of the cylinder changes as a function of time
during the cylindrical phase,
dV(t)/dt =
R20dl(t)/dt. The time rate of change of the length of the cylindrical portion is,
therefore, expressed as
|
(3)
|
The
pressure inside the bubble,
Pb N2[R(t)],
is defined as
Pb N2(R0)
during the time 0
t
T1.
Determination of
Pb N2(R0)
requires some simplifying assumptions. We assume the elastic force
exerted by the vessel wall on the IGE is very small and can be ignored.
We also neglect the effect of the hydrostatic head of blood pressure on
the bubble, because it is very small in comparison to the value of
PB. Finally, we assume the
amount of O2 and
CO2 delivered to the tissue during bubble absorption maintains a steady tissue partial pressure of these
gases. With the use of Laplace's Law, the expression for Pb N2[R(t)]
simplifies to
|
(4)
|
The
external pressure on the bubble,
PT, is the
difference between PB working to
collapse the bubble and
PtiO2, PtiCO2, and
PtiH2O, the
partial pressures of O2,
CO2, and
H2O, respectively, in the tissue.
During the cylindrical phase of gas absorption, the radius of the
hemispherical end caps does not change, and
Pb N2[R(t)]
is written as
Pb N2(R0) = PT + 2
/R0.
The driving force for collapse, dP/dr
at r = R0, must be
solved by using the diffusion equation. To solve for this term in Eq. 3, we begin with
|
(5)
|
First
we substitute C =
ti P',
in which P' = P
PaN2, where P
is the partial pressure of N2 in
the shell around the bubble and
PaN2 is the
partial pressure of N2 in the
incoming arterial blood in locally perfused tissue. Assuming
P'/
t = 0 gives
2P'
2
2P' = 0. In this
expression,
represents the general elimination of
N2 from the tissue and is defined
by
= (
b/2D
ti)1/2,
where the solubility of N2 in
blood is
b and
is tissue perfusion. Accounting for the
flux of N2 across the entire
surface area of the bubble, this expression becomes
|
(6)
|
The
boundary conditions for P'(r) are
|
(7)
|
and
|
(8)
|
The
first boundary condition indicates that there is no gradient in
N2 far from the bubble.
Equation 8 defines the magnitude of
the N2 gradient at the gas-liquid
interface. Subject to these boundary conditions, the exact solution to
Eq. 6 is
|
(9)
|
in
which
Ki(n)
represents a modified Bessel function of the second kind of order
i. Equation 9 can be readily differentiated to evaluate the term
needed to solve Eq. 3
|
(10)
|
Solving Eq. 3 for
l(t)
gives
|
(11)
|
with
|
(12)
|
Equation 11 was solved numerically in Fortran (Lahey Computer
Systems) on a 486-66 PC (Gateway 2000).
Once the IGE geometry becomes spherical, the transport equations are
simpler to solve. The governing equations for
T1
t
T are, again, Fick's Law and the
diffusion equation, and they yield the time rate of change of the
radius, previously defined in Ref. 27 as
|
(13)
|
With the use of the fourth-order Runga-Kutta method,
Eq. 13 was also solved numerically
with Fortran. The time to complete bubble absorption,
T, defined at
R(T) = 0, was calculated to within 0.01 min. Values for the physiological
parameters simulating air bubbles in the cerebral circulation were
obtained from the literature (11). We used
D = 6.22 × 10
4
cm2/min,
ti = 2.092 × 10
5
ml · cm3
brain
1 · mmHg
1,
b = 1.855 × 10
5
ml · ml
blood
1 · mmHg
1,
= 0.525 ml
blood · cm3
brain
1 · min
1,
= 0.0355 mmHg/cm, PB = 760 Torr, PaN2 = 428 Torr,
PtiO2 = 40 Torr,
PtiCO2 = 44 Torr, and
PtiH2O = 47 Torr. Our code was verified by running our model for the spherical case
(l0 = 0) and
comparing the results to those previously published. Our predicted values were within ±3% of the values computed by Dexter and
Hindman (11).
Model predictions for cerebrovascular embolism.
We used the computer model and the same physiological parameters listed
above to predict the absorption time for cerebrovascular bubbles with
identical initial volumes but varying initial geometries by using a
range of l0 and
R0 to define an
aspect ratio, X = l0/R0. The total time for bubble absorption,
T, is
T = T1 + T2, with T1 and
T2 defined as the
time taken for the collapse of the cylindrical and spherical portions,
respectively. The values for
T1 and
T2 are calculated
from Eqs. 11 and 13 to be
|
(14)
|
and
|
(15)
|
in
which
= (2)1/2
. Formally,
Pb N2(R*),
the pressure inside the bubble based on the time-averaged mean of the
radius of the sphere,
R*,
replaces the expression
Pb N2[R(t)],
which behaves in a nonlinear time-dependent fashion. Initially, with
larger values of R,
Pb N2[R(t)]
is small; however, as the radius becomes very small,
Pb N2[R(t)]
becomes extremely large. The nonlinear rise of internal pressure does
not lend to easy calculation of T2; therefore, we
have made the approximation that R
R*. We calculated
the value of R*
as a fraction, n, of the initial
radius: R* = nR0. To find the
value of n, we used the expression
|
(16)
|
Because
each of the integrals in Eq. 16
equivalently represents the area under the radius-time curve, we
evaluate the latter expression, because we can write
T'(R')
explicitly as
T'(R') = T2(R0)
T2(R'),
giving
|
(17)
|
Using Eqs. 15 and 17, we obtain the following expression
for n
|
(18)
|
With this result, we considered a wide range of initial
geometries, X, and bubble volumes.
All computer simulations used to obtain absorption times were run under
very specific conditions. The embolism was assumed to be entrapped air,
at 37°C, in a patient breathing a common postoperative CPB
ventilation mixture [inspired
O2 fraction
(FIO2) = 0.4], at
atmospheric pressure. Any changes in this set of conditions, such as a
different ventilation gas mixture, an increase in external pressure, or
hypothermic conditions, would change one or more of the given variables
in the governing equation and provide a different set of results.
Animal model.
Adult male Wistar rats (n = 5),
weighing 200-425 g, were handled according to specifications set
forth by the Animal Care and Use Committee and the University of
Pennsylvania, in conformance with National Institutes of Health
guidelines. Anesthesia was induced by inhalation of halothane in a
closed chamber with a flow rate large enough to prevent accumulation of
CO2.
After induction, rats were placed in a supine position on a specialized
Plexiglas tray and endotracheally intubated. The animals were
ventilated by using a positive-pressure piston-driven small animal
ventilator with 1.2% halothane in an
air-O2 mixture (0.30
FIO2
0.36). Blood
pressure and heart rate were monitored with a catheter (PE 50) in the
right carotid artery. The ventilation rate and
FIO2 were adjusted to keep
arterial PO2 ~100 Torr and arterial
PCO2 ~35 Torr, based on arterial blood-gas analysis (Corning pH Blood Gas System 168). A PE 50 catheter
was also placed in the left jugular vein for intravenous (iv)
administrations of the muscle relaxant pancuronium bromide (1 mg/kg
iv), if needed. Additional catheters (PE 10) were inserted into the
femoral artery of each leg for injection of air bubbles directly into
the cremaster circulation. Body temperature was monitored with a rectal
thermometer and maintained at 37°C with a heating pad.
The cremaster muscle was prepared as previously described (3, 19).
Briefly, the cremaster muscle was exposed and separated from the
surrounding tissue and organ through a midline incision, first in the
scrotum and then the muscle itself. Loose connective tissue was
carefully dissected away with forceps. The cremaster was then spread
over a transparent pedestal built into the Plexiglas tray. Sutures were
attached in five locations to keep the muscle flat on the platform. The
cremaster was superfused at 2 l/min with a warmed (34°C), gassed
(95% N2-5%
CO2) Kreb's buffer containing (in mmol/l) 132 NaCl, 25 NaHCO3, 5 KCl, 1.2 MgCl2, and 2 CaCl2. The cremaster muscle was
given 30 min to equilibrate before any experimentation was begun.
The cremaster circulation was visualized at a video-microscopy
workstation consisting of a compound microscope (Leitz Wetzlar), high-resolution television camera (Microimage Video CA2063), video image analyzer (Boeckeler VIA-150), monitor (Sony PVM-1343MD), and
videocassette recorder (Panasonic AG1970). The components of this
system enable visualization of arterioles 200-10 µm in diameter,
determination of vessel dimensions with a video micrometer, observation
of erythrocyte motion, and a videotaped recording of the experiment.
An initial record of baseline perfusion was made in the cremaster
circulation after the equilibration period to determine control
conditions of blood flow. To demonstrate the preservation of vascular
responses during the preparation, a 0.75-ml bolus of
10
4 mol/l ACh, diluted in
Kreb's buffer, was added topically to the muscle, and vasodilation was
verified. A discrete series of bubbles, ranging in number from two to
eight and in volume from 50 to 500 nl, was created in the femoral
artery catheter and injected with a small (~0.5-ml) bolus of 0.9%
NaCl, a minimum of 10 min after the application of Ach. The large range
of bubble volumes is permissible because individual bubbles break up
before reaching the cremaster circulation. After injection, the
entrapped bubble was located in the embolized artery and videotaped
over time. In the event the entrapped bubble became dislodged,
movements into the periphery were continuously tracked and recorded.
The bubble was under constant observation until visualization was no
longer possible because of either complete absorption or movement to a
less favorable viewing area. Occasionally, the bubble failed to enter
the cremaster circulation or lodged where visualization was difficult,
in which case the procedure of bubble injection was repeated.
Bubble dimensions were measured every 20 s from the videotape by using
the video micrometer. The volume of the IGE was calculated assuming a
representative geometry (a cylinder with a hemispherical cap on each
end) and axisymmetry in the vessel. Only bubbles with volumes between
1.0 and 6.0 nl were examined. Bubbles that lodged where no tissue
perfusion from collateral vessels was evident were omitted from the
study. Similarly, those bubbles that did not show the cylindrical
geometry with hemispherical end caps were also excluded. This included
bubbles in direct contact with one another, thereby not exhibiting the
hemispherical end caps, or bubbles trapped in vessels with highly
nonuniform diameters. Bubbles that continually changed their
conformation because of constant dislodgment and reentrapment were also
ignored, although occasional movement was permissible.
Validation of theory by experiment.
The absorption times of bubbles from different experiments could not be
compared with one another because of the dependence of the absorption
time on initial bubble volume and the parameters of
l0 and
R0. No two
bubbles in vivo had these same characteristics; therefore, the
absorption times for the experimental bubbles were compared with both
the theoretical model calculated specifically for the initial geometry
in each case and a spherical bubble of the same volume, as shown in
Table 1. The theoretical model was used to
simulate each in vivo bubble by inserting the measured values of
l0 and
R0 and the
physiological parameters corresponding to the experimental conditions
into the Fortran code. The values for the parameters for this case were
estimated to be D = 6.14 × 10
4
cm2/min (2, 29);
ti = 2.103 × 10
5
ml · cm3
muscle
1 · mmHg
1
(2, 29);
= 0.042 ml
blood · cm3
muscle
1 · min
1
(14); and 456 Torr
PaN2
500 Torr
(11). Those values not listed were assumed to remain the same as those
previously defined for the cerebral circulation. From the dimensions of
initial bubble geometry, the program calculated the bubble volume and derived a corresponding initial radius for a spherical bubble of the
same volume. With this initial radius, the computer simulation then
calculated the absorption time for the sphere. For simplicity, bubble
dislodgment to a vessel of different diameter was not accounted for in
the mathematical model, although this situation occasionally occurred
in vivo.
 |
RESULTS |
Preliminary observations.
The air emboli observed in the rat cremaster circulation generally
ranged in volume from 0.2 to 6.0 nl. All bubbles lodged having initial
radii between 30 and 55 µm and initial lengths from 180 to 550 µm.
These dimensions corresponded to an aspect ratio,
X, ranging in value from 4.3 to 11.2. An example of a bubble lodged inside a cremaster arteriole is shown in
Fig. 1A.
In no case were the bubbles observed to pass through the capillaries
and travel into the venous circulation. If the bubble did travel
further downstream after initially lodging in a vessel, bubble movement
could usually be described as "stick and slip." Stick and slip
refers to the fact that the bubbles travel at very inconsistent speeds,
often becoming reentrapped and dislodging several more times in a
vessel of fairly uniform diameter.
Validation of theory by experiment.
To validate our theoretical model, we compared the experimentally
measured absorption times with our theoretical predictions using the
corresponding physiological values and initial bubble volume for both
the in vivo and spherical bubble geometry. The theoretical model
calculated longer absorption times for bubbles with the in vivo
geometry than for spherical bubbles. The predicted differences in
absorption times between the two geometries, in vivo and spherical,
however, proved to be quite variable, depending on the initial
configuration of the experimental bubble being simulated. In the
majority of cases, our model using the in vivo geometry predicted the
experimentally measured absorption times more closely than when the
model assumed a purely spherical bubble. An example of the various
measured and calculated absorption times is presented in Fig.
2. Both geometric models tracked the
initial minutes (~4 min) of experimental bubble absorption well, but
as the bubble volume became small (<0.5 nl), the in vivo
configuration predicted the measured time more closely than did the
spherical geometry. The absorption time of the experimental bubble was
22.0 min, and the accompanying theoretical predictions were 21.1 min with the use of the in vivo configuration and 16.4 min assuming a
spherical shape. In the five cases examined, the predicted values for
absorption times differed overall from the experimental absorption times by 12.1 ± 4.9 (SD)% for the in vivo geometry and by 20.1 ± 12.1% for the spherical configuration. Results from the
predictive model were significantly different for the two geometries
(Student's t-test,
P < 0.01).

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 2.
Measured and predicted absorption times for bubble having initial
volume of 2.8 nl. In vivo measurement (large dotted line), prediction
using initial in vivo bubble dimensions (dashed line), and prediction
assuming spherical bubble of same initial volume (small dotted line)
are shown.
|
|
Model predictions for cerebrovascular embolism.
Our theoretical model was used to calculate the time rate of change of
bubble volume for a cerebrovascular bubble of a given initial volume
under different initial geometric configurations. The bubble volume was
constrained at 2.5 nl, and the total absorption time was found for
X = 0, 2.5, 10, and 20. The
results of the computer simulations are presented in Fig.
3. Each bubble geometry gives a unique
absorption curve based on initial geometry. The spherical bubble,
X = 0, and the highly elongated
bubble, X = 20, are predicted to have
absorption times of 9.3 and 9.4 min, respectively, whereas a bubble of
the same volume with X = 2.5 is
predicted to take 13.3 min to be absorbed. The relationship between
absorption times and X is, therefore,
complex, neither monotonically increasing nor decreasing. The point of
discontinuity in the slope in each of the three curves,
X = 2.5, 10, and 20, represents the transition between the cylindrical and spherical solutions, which is missing, of course, in the purely spherical case.

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 3.
Bubble volume during absorption for different initial aspect ratios
(X = l0 /R0).
All curves are for an initial volume of 2.5 nl. Aspect ratios shown are
spherical bubble X = 0 (solid line),
X = 2.5 (long dashed line),
X = 10 (short dashed
line), and X = 20 (dotted line).
|
|
Calculations of absorption times were also made at fixed initial bubble
volumes (0.5, 2.5, and 10 nl) for varying initial geometries (Fig.
4). A maximum absorption time,
Tmax, exists on each curve of initial bubble volume clustered around
X = 2.6. At
X = 0, the absorption time corresponds
to the time required for an initially spherical bubble to be absorbed,
Tsphere. The predicted Tsphere
for a 10-nl bubble is 22.2 min, whereas
Tmax for the same
volume is predicted to be 33.6 min, an increase of 51% from
Tsphere.

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 4.
Predicted absorption time, T, as a
function of initial bubble aspect ratio,
X. Curves are for fixed initial bubble
volume. Dashed line at X = 2.6 defines
maximum absorption time,
Tmax. Solid lines
at X = 13.1 and
X = 0.3 are upper and lower bounds,
respectively, for absorption times falling within 80% of
Tmax.
|
|
The time required for a spherical bubble to be absorbed is considered
the minimum physiologically realistic absorption time possible.
Although shorter absorption times are predicted, they are for
X
20. With this aspect ratio,
bubbles would have a diameter smaller than a capillary, a geometry we
consider to be physiologically irrelevant. Solid lines at
X = 0.3 and 13.1 in Fig. 4 indicate the range of aspect ratios in which bubble absorption time is within
80% of Tmax. Of
note, all of the in vivo experimental bubble configurations fell within
this range of aspect ratios.
The computer model was used to calculate
TX, the time
required for a bubble of initial volume,
V0, to be absorbed as a function of initial surface area,
A0(X),
over the range 0
X
25. The resulting iso-initial volume curves, presented in Fig.
5, demonstrate the influence of initial
surface area on absorption time. Presenting the data in the surface
area domain resulted in similar trends, as were previously noted in
Fig. 4. This representation of the data uniquely demonstrates that
absorption time is a linear function of initial surface area for a
given value of X over a range of initial bubble volumes. Each curve shown has a unique maximum absorption time as well as a point at the far left corresponding to
Tsphere. The
maximum absorption time for each curve occurs at
X = 2.6. These maxima form a locus of
points linear in
A0(X) with a slope of
m2.6 = 130.9 mm2/min
(R2 = 0.9988).
The values of
Tsphere on each
curve also fall along a straight line having a slope of
m0 = 97.5 mm2/min
(R2 = 0.9940).
The slopes of these two lines were determined by linear regression by
using the points illustrated in Fig. 5 and forcing the result through
the origin. These two slopes were significantly different
(P < 0.001, Student's
t-test to evaluate the difference in
regressions).

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 5.
Dependence of absorption time on initial surface area,
A0(X),
for several initial bubble volumes. Spherical bubbles for each volume
are designated by solid circles, whereas maximum absorption time is
represented by open circles. Lines passing through symbols are
X = 0 (dashed line) and
X = 2.6 (solid line). See text for
explanation of equation.
|
|
By using the equation included in Fig. 5,
TX = mXA0(X),
the following simple expression can be used to determine
TX based only on
initial bubble volume, V0, and the
aspect ratio, X
|
(19)
|
in
which mX is the
slope of the line for a given value of
X. Equation 19, with the values of
m2.6 and
m0 given above,
yields predicted absorption times for
Tmax and
Tsphere very
close to those found by using the computer simulation based on
Eqs. 14 and 15. A comparison of the two methods
can be found in Table 2. This simplified
approach with the use of the predicted slope accurately estimates the
absorption times calculated by the computer model, with an average
error <4% for
Tmax and <6%
for Tsphere.
 |
DISCUSSION |
Validation of theory by experiment.
IGE is unfortunately a frequent and not completely avoidable
complication of CPB surgery that can lead to serious neurological injury or death. To address areas of potential treatments for emboli,
one must first understand the behavior of gas bubbles in the
vasculature as it relates to the bubble's in vivo configuration (Fig.
1A).
Air emboli always remained in the arterial circulation until complete
absorption, although they would occasionally dislodge and flow
downstream. Transcapillary bubble passage has been reported (13, 26);
however, we did not observe bubbles lodged in the venous circulation.
This is because, at volumes small enough to fit into the capillaries,
bubbles collapsed at a rate faster than they could physically move to
the venules.
We have only applied our model to arterial air embolism absorption;
however, bubbles have also been shown to enter the venous circulation
(8), and they have frequently been observed intraoperatively by one of
the authors (D. M. Eckmann) in the cephalic vein of surgical patients
undergoing placement of a permanent central venous catheter. Those
instances have been limited to patients having a distal peripheral iv
catheter in the ipsilateral upper extremity, indicating air
introduction through the iv catheter.
Our model, however, can easily be adapted to consider venous gas
embolism, if desired. In the absence of external or interfacial stresses, surface tension dictates that bubbles would most prefer to
assume a spherical shape, to minimize the surface area for a given
volume. The increased distensibility of the venous vessels may
initially allow bubbles to lodge more closely to their spherical configuration than if entrapped in the arteries. The inability of veins
to vasoconstrict to the same degree as arteries makes it less likely
that bubble dimensions, and therefore internal pressure, will change
after entrapment.
The stick-and-slip movement observed by bubbles throughout the arterial
vasculature has tribological implications of interfacial interactions
between various physiological components. A layer of denatured proteins
has been seen at the bubble-blood interface in vivo (21, 30). This
network of denatured proteins may have some complex adhesive
interactions with the glycocalyx or the endothelial cell membrane (10,
31). In addition, there may be other types of interactions present at
the air-blood-vessel interface that affect interfacial mechanics such
as contact-angle hysteresis with wetting and dewetting phenomena (4,
7).
The present theoretical model, taking the specific geometry of the in
vivo IGE into account, was validated by using data from our animal
experiments. Comparing the absorption times predicted by the theory to
the measured absorption times demonstrated that using the in vivo
configuration (X
0) in the
model led to predicted times that were significantly different from
times calculated assuming a spherical shape
(X = 0) and that more accurately
matched the experimental data (Table 1).
Despite the improved accuracy, our model still underestimated the time
of absorption in a majority of cases, compared with the animal data.
This discrepancy may be due to the fact that the blood-borne matter
that absorbs to the bubble interface potentially inhibits gas diffusion
and prolongs bubble absorption (6, 28) but has not yet been taken into
account in our mathematical model.
Model predictions for cerebrovascular embolism.
The initial aspect ratio is an extremely important factor in
determining the absorption time of an intravascular bubble, as seen
from Eq. 14. The direct effect of the
aspect ratio on the time rate of change of bubble volume is
demonstrated in Fig. 3, in which a 2.5-nl bubble has markedly different
absorption curves depending on initial geometry. The theoretical model,
simulating cerebral IGEs, predicts that there exists a value of
X = l0 /R0
2.6, which results in a maximum absorption time that is as much as
51% greater than if absorption is calculated for a spherical bubble
with the same initial volume. All of the experimental IGEs lodged with
initial geometries that were near the peaks of the curves shown in
Figs. 4 and 5, suggesting the in vivo bubbles lodge in configurations
associated with longer absorption times.
The nonlinearity of absorption times as a function of aspect ratio,
seen in Fig. 4, cannot be explained purely as an increase in initial
bubble surface area leading to decreased absorption time (Fig. 5). This
demonstrates that additional competing mechanisms are at work, such as
constant internal bubble pressure. Both the maximum absorption time and
the absorption time for a spherical bubble are linear functions of
initial surface area over a range of bubble volumes, and the slopes of
each of these lines are significantly different from one another. The
results of these linear approximations can be used to construct an
accurate simplified estimate of absorption time, as shown in Table 2.
It is apparent that there is little difference in the bubble absorption
times calculated by the full computer model and those times estimated
with Eq. 19. Using
Eq. 19 and a value of the aspect ratio
at 2.6 or 0, therefore, provides a very simple, accurate means of
predicting the maximum and minimum time of bubble absorption,
respectively, given the initial volume. This slope equation could be
useful in trying to estimate the bounds of residence time of bubbles
found entrapped in the cerebral circulation, say by computed tomography
or magnetic resonance imaging, and deciding whether or not to invoke a
therapy such as hyperbaria.
The theoretical model lends considerable insight into the role of
bubble geometry on the residence time of IGEs. In a clinical context,
one would desire to minimize this or eliminate gas bubbles from the
circulation altogether. Present methods of treatment include hyperbaric
therapy and ventilation with gases containing lower concentrations of
N2. One avenue that still remains
largely unexplored is manipulating bubble geometry, perhaps with the
help of surface active agents. Inducing the bubbles to break up (25), or lodge with an elongated shape (X > 15), could potentially minimize the time for bubble absorption and
until tissue blood flow is resumed. There are several additional issues
associated with bubble geometry that must also be considered when
assessing the potential adverse effects of a particular IGE conformation.
Whereas highly elongated (large X)
bubbles are predicted to have a shorter residence time in the embolized
vessel, a longer initial bubble length increases the contact area
between the bubble and the endothelium. Endothelial cells are very
susceptible to damage caused by contact with air and have been shown to
release from the basement membrane or form gaps after being exposed to bubbles (1, 31). A larger surface area may also potentiate the
activation of thromboinflammatory pathways. This induces additional responses, including platelet aggregation and local neutrophil sequestration (1, 21).
Bubbles lodging as spheres may minimize absorption time and endothelial
contact area but may have other associated negative effects. Bubbles
remaining close to the spherical shape after lodging would have the
largest initial radius possible for a given volume. The embolized
vessel in this case would be of larger diameter than if the bubble were
elongated. Occluding a vessel of larger diameter could block blood flow
and O2 delivery to a larger
vascular territory. The area of tissue ischemia and severity of
neurological damage, therefore, would potentially be increased.
Clearly, physics and physiology related to IGEs are extremely complex.
The theoretical model presented, based on in vivo bubble geometry, now
allows some new issues heretofore ignored to be addressed. We have
shown the importance of incorporating bubble geometry when the
residence times of intravascular bubbles are predicted. With this
theoretical model, we accurately predict the actual bubble absorption
times measured in vivo. It is important to stress that these results
apply to only one specific set of conditions: cerebral air embolism in
a patient with normal blood gases at sea level and 37°C. Situations
arise that would change these results and would have to be accounted
for in the computer model. These situations include ventilating
patients with different gas mixtures such as He and
O2, placing patients in a
hyperbaric chamber, which increases the external pressure, or cooling
or warming patients during CPB. By altering different parameters to
simulate clinical situations, use of this model can be extended to
predict the effects of various therapeutic maneuvers on their ability
to accelerate IGE absorption. Such computer simulations may help form a
better understanding of the factors influencing the deposition and
absorption of cerebrovascular gas bubbles and lead the way for the
development of more effective and innovative strategies in dealing with
this important clinical problem.
 |
ACKNOWLEDGEMENTS |
Dr. Alex Loeb and Dareus Conover provided helpful advice.
 |
FOOTNOTES |
The Whitaker Foundation and National Heart, Lung, and Blood Institute
Grant R01-HL-60230 were funding sources for this work.
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement"
in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Address for reprint requests and other correspondence: D. M. Eckmann,
Dept. of Anesthesia, Univ. of Pennsylvania, 7-Dulles/HUP, 3400 Spruce
St., Philadelphia, PA 19104 (E-mail: deckmann{at}mail.med.upenn.edu).
Received 16 February 1999; accepted in final form 8 June 1999.
 |
REFERENCES |
1.
Albertine, K. H.,
J. P. Wiener-Kronish,
K. Koike,
and
N. C. Staub.
Quantification of damage by air emboli to lung microvessels in anesthetized sheep.
J. Appl. Physiol.
57:
1360-1368,
1984[Abstract/Free Full Text].
2.
Altman, P. L.,
and
D. S. Dittmer.
Respiration and Circulation. Bethesda, MD: FASEB, 1971.
3.
Baez, S.
An open cremaster muscle preparation for the study of blood vessels by in vivo microscopy.
Microvasc. Res.
5:
384-394,
1995.
4.
Baier, R. E.,
R. C. Dutton,
and
V. L. Gott.
Surface chemical features of the blood vessel walls.
In: Surface Chemistry of Biological Systems, edited by M. Black. New York: Plenum, 1970, p. 235.
5.
Burkard, M. E.,
and
H. D. Van Liew.
Simulation of exchanges of multiple gases in bubbles in the body.
Respir. Physiol.
95:
131-145,
1994[Medline].
6.
Butler, B. D.
Biophysical aspects of gas bubbles in blood.
Med. Instrum.
19:
59-62,
1985[Medline].
7.
Cavanagh, D. P., and D. M. Eckmann. Interfacial dynamics of
stationary gas bubbles in flows in inclined tubes. J. Fluid
Mech. In press.
8.
Chan, K. S.,
and
W. J. Yang.
Survey of literature related to the problems of gas embolism in human body.
J. Biomech.
2:
299-312,
1969.
9.
Clark, R. E.,
J. Brillman,
D. A. Davis,
M. R. Lovell,
J. R. Price,
and
G. J. Magovern.
Microemboli during coronary artery bypass grafting.
J. Thorac. Cardiovasc. Surg.
109:
249-258,
1995[Abstract/Free Full Text].
10.
Damiano, E. R.
The effect of the endothelial-cell glycocalyx on the motion of red blood cells through capillaries.
Microvasc. Res.
55:
77-91,
1998[Medline].
11.
Dexter, F.,
and
B. J. Hindman.
Recommendations for hyperbaric oxygen therapy of cerebral air embolism based on a mathematical model of bubble absorption.
Anesth. Analg.
84:
1203-1207,
1997[Abstract].
12.
Feinstein, S. B.,
P. M. Shah,
R. J. Bing,
S. Meerbaum,
E. Corday,
B.-L. Chang,
G. Santillan,
and
Y. Fujibayashi.
Microbubble dynamics visualized in the intact capillary circulation.
J. Am. Coll. Cardiol.
4:
595-600,
1984[Abstract].
13.
Geoghegan, T.,
and
C. R. Lam.
The mechanism of death from intracardiac air and its reversibility. Ann. Surg., 1953, p. 351-359.
14.
Guyton, A. C.,
and
J. E. Hall.
Textbook of Medical Physiology. Philadelphia, PA: Saunders, 1996.
15.
Helps, S. C.,
M. Meyer-Witting,
P. L. Reilly,
and
D. F. Gorman.
The effect of emboli on rabbit cerebral blood flow.
Stroke
21:
94-99,
1990[Abstract/Free Full Text].
16.
Herren, J. I.,
K. S. Kunzelman,
C. Vocelka,
R. P. Cochran,
and
B. D. Spiess.
Angiographic and histological evaluation of porcine retinal vascular damage and protection with perfluorocarbons after massive air embolism.
Stroke
29:
2396-2403,
1998[Abstract/Free Full Text].
17.
Hlastala, M. P.,
and
H. D. Van Liew.
Absorption of in vivo inert gas bubbles.
Respir. Physiol.
24:
147-158,
1975[Medline].
18.
Kort, A.,
and
I. Kronzon.
Microbubble formation: in vitro and in vivo observation.
J. Clin. Ultrasound
10:
117-120,
1982[Medline].
19.
Loeb, A. L.,
I. Godeny,
and
D. E. Longnecker.
Anesthetics alter relative contributions of NO and EDHF in rat cremaster muscle microcirculation.
Am. J. Physiol.
273 (Heart Circ. Physiol. 42):
H618-H627,
1997[Abstract/Free Full Text].
20.
Padayachee, T. S.,
S. Parsons,
R. Theobold,
J. Linley,
R. G. Gosling,
and
P. B. Deverall.
The detection of microemboli in the middle cerebral artery during cardiopulmonary bypass: a transcranial doppler ultrasound investigation using membrane and bubble oxygenators.
Ann. Thorac. Surg.
44:
298-302,
1987[Abstract].
21.
Philp, R. B.,
M. J. Inwood,
and
B. A. Warren.
Interactions between gas bubbles and components of the blood: implications in decompression sickness.
Aerosp. Med.
43:
946-953,
1972[Medline].
22.
Roach, G. W.,
M. Kanchuger,
C. M. Mangano,
M. Newman,
N. Nussmeier,
R. Wolman,
A. Aggarwal,
K. Marschall,
S. H. Graham,
C. Ley,
G. Ozanne,
and
D. T. Mangano.
Adverse cerebral outcomes after coronary bypass surgery. Multicenter study of perioperative ischemia research group and the ischemia research and education foundation investigators.
N. Engl. J. Med.
335:
1857-1863,
1996[Abstract/Free Full Text].
23.
Ryu, K. H.,
B. J. Hindman,
D. K. Reasoner,
and
F. Dexter.
Heparin reduces neurological impairment after cerebral arterial air embolism in the rabbit.
Stroke
27:
303-310,
1996[Abstract/Free Full Text].
24.
Smith, P. L., S. P. Neuman, P. J. Ell, T. Treasure, P. Joseph, A. Schneidau, and M. J. Harrison. Cerebral consequences of cardiopulmonary bypass.
Lancet: 823-825, 1986.
25.
Tsai, T. M.,
and
M. J. Miksis.
The effects of surfactant on the dynamics of bubble snap-off.
J. Fluid Mech.
337:
381-410,
1997.
26.
Van Allen, C. M.,
L. S. Hrdina,
and
J. Clark.
Air embolism from the pulmonary vein: a clinical and experimental study.
Arch. Surg.
19:
567-599,
1929.
27.
Van Liew, H. D.,
and
M. P. Hlastala.
Influence of bubble size and blood perfusion on absorption of gas bubbles in tissues.
Respir. Physiol.
7:
111-121,
1969[Medline].
28.
Van Liew, H. D.,
and
S. Raychaudhuri.
Stabilized bubbles in the body: pressure-radius relationships and the limits to stabilization.
J. Appl. Physiol.
82:
2045-2053,
1997[Abstract/Free Full Text].
29.
Vaupel, P.
Effect of percentual water content in tissues and liquids on the diffusion coefficients of O2, CO2, N2, and H2.
Pflügers Arch.
361:
201-204,
1976[Medline].
30.
Vroman, L.,
A. L. Adams,
and
M. Klings.
Interactions among human blood proteins at interfaces.
Fed. Proc.
30:
1494-1502,
1971[Medline].
31.
Warren, B. A.,
R. B. Philp,
and
M. J. Inwood.
The ultrastructural morphology of air embolism: platelet adhesion to the interface and endothelial damage.
Br. J. Exp. Pathol.
54:
163-172,
1973[Medline].
J APPL PHYSIOL 87(4):1287-1295
8570-7587/99 $5.00
Copyright © 1999 the American Physiological Society